Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Nishiguchi

Showing results (291-300 of 303) with videos related to

Pageof 31
Sort By:
Journal of Hepatology|January 7, 2015
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infectionPeter Ferenci, Tarik Asselah, Graham R Foster, et al.
Journal of Gastroenterology|July 16, 2020
Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis BAkihiro Matsumoto, Shuhei Nishiguchi, Hirayuki Enomoto, et al.
Nature Genetics|September 15, 2009
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis CYasuhito Tanaka, Nao Nishida, Masaya Sugiyama, et al.
Journal of Gastroenterology|June 22, 2017
Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapyAkihiro Matsumoto, Shuhei Nishiguchi, Hirayuki Enomoto, et al.
Journal of Clinical Medicine Research|March 28, 2018
The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver DiseaseKazuhiro Katayama, Takumi Kawaguchi, Koichi Shiraishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 8, 2006
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in JapanFuminaka Sugauchi, Etsuro Orito, Tomoyoshi Ohno, et al.
Human Genetics|December 18, 2014
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis CEtsuko Iio, Kentaro Matsuura, Nao Nishida, et al.
Regenerative Therapy|May 13, 2024
Hepatic arterial infusion of autologous CD34<sup>+</sup> cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trialToru Nakamura, Atsutaka Masuda, Makoto Kako, et al.
Global Health & Medicine|September 19, 2022
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapyMasaaki Korenaga, Kazumoto Murata, Namiki Izumi, et al.
Journal of Viral Hepatitis|September 9, 2014
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trialMasao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno, et al.
Pageof 31

Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Journal of Hepatology|January 7, 2015
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infectionPeter Ferenci, Tarik Asselah, Graham R Foster, et al.
Journal of Gastroenterology|July 16, 2020
Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis BAkihiro Matsumoto, Shuhei Nishiguchi, Hirayuki Enomoto, et al.
Nature Genetics|September 15, 2009
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis CYasuhito Tanaka, Nao Nishida, Masaya Sugiyama, et al.
Journal of Gastroenterology|June 22, 2017
Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapyAkihiro Matsumoto, Shuhei Nishiguchi, Hirayuki Enomoto, et al.
Journal of Clinical Medicine Research|March 28, 2018
The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver DiseaseKazuhiro Katayama, Takumi Kawaguchi, Koichi Shiraishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 8, 2006
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in JapanFuminaka Sugauchi, Etsuro Orito, Tomoyoshi Ohno, et al.
Human Genetics|December 18, 2014
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis CEtsuko Iio, Kentaro Matsuura, Nao Nishida, et al.
Regenerative Therapy|May 13, 2024
Hepatic arterial infusion of autologous CD34<sup>+</sup> cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trialToru Nakamura, Atsutaka Masuda, Makoto Kako, et al.
Global Health & Medicine|September 19, 2022
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapyMasaaki Korenaga, Kazumoto Murata, Namiki Izumi, et al.
Journal of Viral Hepatitis|September 9, 2014
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trialMasao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno, et al.
Pageof 31